Live Breaking News & Updates on Applied Genetic Technologies Corporation

Stay updated with breaking news from Applied genetic technologies corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Third Company Launch underpinned by promising Opthalmic Programmes

With £96 million Series A financing, Lifescience company developer Syncona has launched Beacon Therapeutics Holdings, a leading ophthalmic gene therapy company focused on restoration and improvement of vision of patients with retinal diseases. Click to read more. ....

Nadia Waheed , Robert Maclaren , Abraham Scaria , Beacon Therapeutics Holdings , Genetic Technologies Corporation , University Of Oxford , Oxford Science Enterprises , Applied Genetic Technologies Corporation , Beacon Therapeutics , Beacon Therapeutic , Chief Executive Officer , Chief Medical Officer , Chief Scientific ,